These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3086716)

  • 1. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
    Ishii K; Maeda K; Kamataki T; Kato R
    Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of hepatic cytochrome P-450 isoenzymes from PCB-treated rats and participation of cytochrome b5 in the activation of aflatoxin B1.
    Ueno Y; Ishii K; Omata Y; Kamataki T; Kato R
    Carcinogenesis; 1983 Aug; 4(8):1071-3. PubMed ID: 6409444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes.
    Shimada T; Nakamura S; Imaoka S; Funae Y
    Toxicol Appl Pharmacol; 1987 Oct; 91(1):13-21. PubMed ID: 3118508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of two inducible forms of cytochrome P-450 in rat liver microsomes to the metabolic activation of various chemical carcinogens.
    Kawajiri K; Yonekawa H; Gotoh O; Watanabe J; Igarashi S; Tagashira Y
    Cancer Res; 1983 Feb; 43(2):819-23. PubMed ID: 6401224
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation and inactivation of a variety of mutagenic compounds by the reconstituted system containing highly purified preparations of cytochrome P-450 from rat liver.
    Kawano S; Kamataki T; Maeda K; Kato R; Nakao T; Mizoguchi I
    Fundam Appl Toxicol; 1985 Jun; 5(3):487-98. PubMed ID: 3924696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of highly purified cytochrome P-450 isozymes in the activation of 4-aminobiphenyl to mutagenic products in the Ames test.
    Masson HA; Ioannides C; Gorrod JW; Gibson GG
    Carcinogenesis; 1983 Dec; 4(12):1583-6. PubMed ID: 6418403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.
    Forrester LM; Neal GE; Judah DJ; Glancey MJ; Wolf CR
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8306-10. PubMed ID: 2122459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of three forms of cytochrome P-450 inducible by 3-methylcholanthrene in Golden hamster livers with special reference to aflatoxin B1 activation.
    Fukuhara M; Nohmi T; Mizokami K; Sunouchi M; Ishidate M; Takanaka A
    J Biochem; 1989 Aug; 106(2):253-8. PubMed ID: 2509440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.
    Kamataki T; Maeda K; Yamazoe Y; Matsuda N; Ishii K; Kato R
    Mol Pharmacol; 1983 Jul; 24(1):146-55. PubMed ID: 6408394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation of glutamic acid pyrolysis products, 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole and 2-amino-dipyrido[1,2-a:3',2'-d]imidazole, by purified cytochrome P-450.
    Ishii K; Yamazoe Y; Kamataki T; Kato R
    Chem Biol Interact; 1981 Dec; 38(1):1-13. PubMed ID: 6120046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism, covalent binding, and mutagenicity of aflatoxin B1 by liver extracts from rats of various ages.
    Jayaraj A; Hardwick JP; Diller TW; Richardson AG
    J Natl Cancer Inst; 1985 Jan; 74(1):95-103. PubMed ID: 3918213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis.
    San RH; Chan RI
    Mutat Res; 1987 Apr; 177(2):229-39. PubMed ID: 3104775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains.
    Uwaifo AO; Bababunmi EA
    Cancer Lett; 1979 Aug; 7(4):221-5. PubMed ID: 389414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of emodin in the reconstituted cytochrome P-450 system of the hepatic microsomes of rats.
    Tanaka H; Morooka N; Haraikawa K; Ueno Y
    Mutat Res; 1987 Feb; 176(2):165-70. PubMed ID: 3100945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aflatoxin B1 metabolism by 3-methylcholanthrene-induced hamster hepatic cytochrome P-450s.
    Lai TS; Chiang JY
    J Biochem Toxicol; 1990; 5(3):147-53. PubMed ID: 2126562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the activation of aflatoxin B1 catalysed by the same form of cytochrome P-450 as that 4-hydroxylating debrisoquine in rat and/or man?
    Plummer S; Boobis AR; Davies DS
    Arch Toxicol; 1986 Feb; 58(3):165-70. PubMed ID: 3083802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsomal activation of 2-amino-3-methylimidazo[4,5-f]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate.
    Yamazoe Y; Shimada M; Kamataki T; Kato R
    Cancer Res; 1983 Dec; 43(12 Pt 1):5768-74. PubMed ID: 6416669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Methoxy-4-aminoazobenzene, a unique carcinogenic aromatic amine as a substrate for cytochrome-P-450-mediated mutagenesis.
    Degawa M; Kojima M; Hashimoto Y
    Mutat Res; 1985; 152(2-3):125-9. PubMed ID: 3934534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic mitochondrial cytochrome P-450 system. Distinctive features of cytochrome P-450 involved in the activation of aflatoxin B1 and benzo(a)pyrene.
    Niranjan BG; Wilson NM; Jefcoate CR; Avadhani NG
    J Biol Chem; 1984 Oct; 259(20):12495-501. PubMed ID: 6436235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.